Babies who receive an RV3-BB rotavirus vaccine at birth showed higher levels of good bacteria in their gut, better protecting them against infection during the first weeks of life, according to a new study. And the discovery will help to pave the way for researchers to improve the health outcomes of young children with severe rotavirus gastroenteritis, especially those living in low-income countries.